The comparison of the effectiveness of health technologies is not only laid down in German law (Social Code Book V, § 139 and § 35b) 
Discussion
The selection of an appropriate method for an indirect comparison has to account for its validity, the number of interventions to be compared and the quality as well as the quantity of available studies. Unadjusted indirect comparisons provide, contrasted with the results of direct comparisons, a low validity. Adjusted indirect comparisons and MTC may, under certain circumstances, give results which are consistent with the results of direct comparisons. The limited number of available reviews utilizing metaregression analyses for indirect comparisons currently prohibits empirical evaluation of this methodology.
Conclusions/Recommendations
Given the main prerequisite -a pool of homogenous and high-quality RCT -the results of head-to-head trials may be pre-estimated by an adjusted indirect comparison or a MTC. In the context of HTA and guideline development they are valuable tools if there is a lack of a direct comparison of the interventions of interest.
Zusammenfassung Gesundheitspolitischer Hintergrund
Die vergleichende Nutzenbewertung von gesundheitsrelevanten Technologien ist nicht nur gesetzlich festgeschrieben ( § 139 und § 35b, SGB V: SGB = Sozialgesetzbuch), sondern ist auch ein zentrales Element von klinischen Leitlinien bzw. Entscheidungssituationen. Entscheidungsunterstützungsinstrumente wie Health Technology Assessments (HTA) sollten daher über ein valides methodisches Instrumentarium verfügen.
Wissenschaftlicher Hintergrund
Randomisierte kontrollierte Head-to-head-Studien, die In addition, reference lists of the main methodological papers and systematic reviews as well as the homepages of the member institutions of the International network of agencies for Health Technology Assessment (INAHTA) are screened for relevant papers. The description of the different methodological approaches for indirect comparisons is based as far as possible on information from methodological papers and completed by information from methods chapters of published applications. Their application frequency is calculated by counting the number of applications in all systematic reviews with indirect comparisons published 1999 to 2008. Indirect comparisons which use metaanalysis techniques are validated empirically on the basis of systematic reviews that report results of direct as well as indirect comparisons. For every methodological approach the following hypothesis is tested: the results of the indirect comparison do not differ significantly from the results of the direct comparison. In order to test this hypothesis the difference in the results of a direct and an indirect comparison for the same intervention is calculated. This difference is named discrepancy. In order to make discrepancies from different reviews comparable, they are transformed into z-scores. The final validity check for the different methodological approaches for indirect comparisons was performed in four steps.
1. Test for systematic over-or underestimation: Are the z-scores normally distributed with an average value of z = 0 (Kolmogorov-Smirnov-Test, p≤0.05)? 2. Quantification of the amount of discrepancy: Calculation of the mean absolute value of z (absolute value of the mean of z-scores). 3. Determination of the share of statistically discrepant z-scores (absolute value of the mean of z-scores ≥1.96) among all z-scores. 4. For data sets with statistically significant discrepant z-scores: Homogeneity testing of the underlying study pool for the direct and indirect comparisons.
Finally it is reported in how many cases the direct and indirect comparisons arrive at the same conclusions.
While it is assumed that inclusion of head-to-head trials into indirect comparisons may level out discrepancies between direct and indirect comparison, the validity check (main analysis) is repeated in a subgroup of data sets (subgroup analysis), which do not include results from head-to-head trials into indirect comparisons.
Results

Method descriptions
Literature reveals that all methodological approaches for indirect comparisons are based on the same assumption:
The observed variability among the results of studies that are going to be included into an indirect comparison is solely due to random error or -in other words -no meaningful between-study heterogeneity is present. Four frequently applied methodological approaches for indirect comparisons, which use metaanalytical methods, are identified:
1. In an unadjusted indirect comparison the comparison of an intervention A with an intervention B is prepared by metaanalytically pooling the results of all study arms treated with A to get a summary estimate θ A and by doing the same in a second metaanalysis with all study arms treated with B to get θ B . 
Validity check
For the validity check of the indirect approaches a total of 248 paired results from direct and indirect comparisons (z-scores) are available from 57 systematic reviews. The test for systematic over-or underestimation reveals that none of the approaches for indirect comparisons systematically over-or underestimates the results of a corresponding direct comparison. Nevertheless, differences in the mean absolute z-scores are observed among the indirect methods: The largest are found with the unadjusted indirect comparisons (absolute value of the mean of z-scores = 
Precision of indirect comparisons
In the analysed sample (n=248) the confidence intervals around the effect estimates of the indirect comparisons are found to be slightly smaller than those around the direct estimates (median difference: 9 % (25th percentile: -34%; 75th percentile: 30%) while the indirect comparisons include six times more studies than the direct comparisons (median: 6 (25th percentile: 4; 75th percentile: 13)). It may therefore be stated that for the analysed sample a six to one ratio of included studies (with an approximately equal number of participants) for the indirect and direct comparison yields almost comparable precision of effect estimates. This supports the claim of Glenny et al. that an indirect comparison must include four times as many studies (of equal size) as a direct comparison to yield the same precision.
Discussion
In decision making whether, and if so, which approach of indirect comparisons should be applied, four criteria should be taken into consideration:
Validity of the methodological approach
Compared to the results of head-to-head trials unadjusted indirect comparison provide the lowest validity. Some authors blame the method for breaking the randomisation of the included RCT because effects are not adjusted for events in the control groups. Therefore results are easily distorted by all types of biases that are normally typical for observational studies (i. e. selection bias and confounding).
In contrast the adjusted indirect comparison, the metaregression and the MTC adjust for events in the control groups and hereby preserve the randomisation of the included RCT. However, a selection bias on the meta-level may still appear if the included studies for one intervention use different inclusion criteria than the studies for the other intervention. The resulting unevenly distributed patient characteristics may, if they are associated with the outcome, act as confounders. Therefore the introduced methods for indirect comparisons should be applied only if the results that are going to be pooled are extracted from homogeneous studies. This prerequisite holds not only for the methodological approaches to indirect comparisons but for conventional metaanalyses as well. These theoretical aspects are supported by the results of the empirical validity check. Adequate numbers of data were available to support the hypothesis that -provided a homogeneous pool of studies -adjusted indirect comparisons may arrive at the same results as direct comparisons. Likewise a high validity can be ascribed to MTC, if they include head-to-head studies with the interventions of interest. The validity of metaregression-analyses, MTC without included head-to-head trials and the rarely used other methods cannot be appraised yet due to a limited number of available applications.
Number of therapies to compare
If only two interventions are to be compared indirectly the adjusted indirect comparison seems to be the most appropriate methodological approach considering the validity data and the limited methodological effort. If more than two interventions are to be compared, only a MTC is applicable to rank them in order of their efficacy.
If results from head-to-head trials are to be included
Beside MTC the three other methods for indirect comparisons also provide methodological extensions for the inclusion of head-to-head trials into an indirect comparison. However there haven't been sufficient data for a check of their validity. It can only be stated yet that MTC which include head-to-head trials yield similar results as the head-to-head trial alone. Their additional advantage is the possible increase in precision of the effect estimate by combining the results of direct and indirect comparisons.
Heterogeneous trials
The indirect comparison by metaregression-analysis cannot yet be regarded a sufficiently validated method that trustworthily adjusts for factors that cause heterogeneity. Likewise adjusting for covariates in MTC by introduction of inconsistency factors has not been validated due to the limited number of applications. In conclusion: If considerable heterogeneity is present among the trials, the risk of bias in indirect comparisons is high -regardless of what methodological approach is used. In cases of low heterogeneity a conservative estimate may be calculated by a random effects model. Fixed effects models should only be applied in homogenous pools of studies. Both models are applicable in all methodological approaches for indirect comparisons described.
Conclusions
There are a number of methodological approaches available for indirect comparisons which differ in their ability to summarize the evidence from different pools of studies. 
Kongruenz in den Schlussfolgerungen
In knapp der Hälfte der 248 Gegenüberstellungen liegt sowohl im direkten als auch im indirekten Vergleich kein signifikanter Therapieeffektunterschied vor (49,2%; 95%-KI: 43,0%; 55,4%). Am zweithäufigsten wird sowohl vom indirekten als auch vom direkten Vergleich die gleiche Therapieoption als signifikant überlegen erkannt (21,8%; 95%-KI: 16,6%; 26,9%). In den restlichen 29% (95%-KI: 23,4%; 34,7%) der Fälle erzielen der direkte und der indirekte Vergleich keine Übereinstimmung in ihren Schlussfolgerungen. Der gefürchtete Fall, dass direkter und indirekter Vergleich jeweils das andere Therapieverfahren als signifikant überlegen erachten, kann allerdings nur in fünf Fällen (Anteil 2%; 95%-KI: 0,3%; 3,8%) beobachtet werden.
Präzision indirekt vergleichender Methoden
In der untersuchten Stichprobe (n=248) besitzt der Effektschätzer des indirekten Vergleichs eine im Median um 9% geringere Konfidenzintervallweite als der direkte Vergleich (25. Perzentil: -34%; 50. Perzentil (Median): -9%; 75. Perzentil: 30%). Gleichzeitig beinhalten diese indirekten Vergleiche im Median exakt sechsmal so viele Studien wie die direkten Vergleiche (25. Perzentil: 4; 75. Perzentil: 13 
Anzahl der zu vergleichenden Therapien
Sollen nur zwei Therapieverfahren indirekt miteinander verglichen werden, bietet sich unter Berücksichtigung der Ergebnisvalidität und des methodischen Aufwandes vor allem der Einsatz eines adjustierten indirekten Vergleichs an. Sollen jedoch mehr als zwei Therapien einander gegenüber gestellt werden, ist nur der MTC einsetzbar, um diese in eine Rangfolge hinsichtlich ihrer Wirksamkeit zu bringen. 
Einschluss von Head-to-head-Studien
